China Veterinary Medicine Market Analysis Report 2024-2030, Featuring China Animal Husbandry Industry, Boehringer Ingelheim, Bimeda, Merck, CEVA, Zoetis Services, Virbac and Vetoquinol [Ya...
SUMITOMO CHEM UNSP/ADR (SOMMY)
NASDAQ:AMEX Investor Relations:
sumitomo-chem.co.jp/english/ir
Company Research
Source: Yahoo! Finance
Analysis Report by Product (Biologics, Pharmaceuticals), Animal Type (Production Animals, Companion Animals), Route Of Administration, Distribution Channel, and Segment Forecasts, 2024-2030" report has been added to ResearchAndMarkets.com's offering. The China veterinary medicine market size is anticipated to reach USD 5.39 billion by 2030, expanding at a CAGR of 8.2% during the forecast period. The emergence of new animal diseases and the increasing need to address those diseases in China are some of the factors contributing to the market growth. For instance, in March 2019, DS Pharma Animal Health Co., Ltd., Sumitomo Corporation, and Shandong Sinder Technology Co., Ltd. made an agreement to license and sell the antiepileptic drug CONSAVE in China by 2022 to deal with epilepsy, a chronic disorder in dogs. China is home to one of the largest pet populations in the world. This huge population of pet animals increases the demand for veterinary medicines in the country as pet owners
Show less
Read more
Impact Snapshot
Event Time:
SOMMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SOMMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SOMMY alerts
High impacting SUMITOMO CHEM UNSP/ADR news events
Weekly update
A roundup of the hottest topics
SOMMY
News
- Poxel Provides a Financial Update for the First Quarter 2024 and Announces the Postponement of its 2023 Full-Year Results Release [Yahoo! Finance]Yahoo! Finance
- Roivant announces $1.5B share buyback, positive Phase 2 data Apr. 02, 2024 9:20 AM ET By: Val Brickates Kennedy , SA News Editor [Seeking Alpha]Seeking Alpha
- Poxel to Report Its 2023 Annual Results by the End of April 2024 [Yahoo! Finance]Yahoo! Finance
- Sumitomo Chemical and Valent BioSciences Announce Divestiture of Pace International and Future Collaboration with AgroFresh Solutions in the Postharvest Solutions Space [Yahoo! Finance]Yahoo! Finance
- Sumitomo Chemical and Valent BioSciences Announce Divestiture of Pace International and Future Collaboration with AgroFresh Solutions in the Postharvest Solutions SpaceBusiness Wire